amgevita 40 mg0.8 ml solution for injection in pre-filled autoinjector
amgen biopharmaceuticals malaysia sdn bhd - adalimumab -
evenity
amgen europe b.v. - romosozumab - solution for injection - romosozumab 90 mg / 1 ml - romosozumab - evenity is indicated for the treatment of severe osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.
amgevita solution for injection in prefilled autoinjector 40 mg0.8 ml
amgen biotechnology singapore pte ltd - adalimumab - injection, solution - adalimumab 40mg/0.8ml
amgevita solution for injection in prefilled syringe 20 mg0.4 ml
amgen biotechnology singapore pte ltd - adalimumab - injection, solution - adalimumab 20 mg/0.4 ml
amgevita solution for injection in prefilled syringe 40 mg0.8 ml
amgen biotechnology singapore pte ltd - adalimumab - injection, solution - adalimumab 40 mg/0.8 ml
inflamgen 500 mg tablet
eba generisch trading inc. - mefenamic acid - tablet - 500 mg
inflamgen 500 mg capsule
eba generisch trading inc. - mefenamic acid - capsule - 500 mg
inflamgen 250 mg capsule
eba generisch trading inc. - mefenamic acid - capsule - 250 mg
inflamgen 50 mg/ 5 ml suspension
eba generisch trading inc. - mefenamic acid - suspension - 50 mg/ 5 ml
inflamgen tab 250 mg film-coated tablet
eba generisch trading inc.; importer: n/a; distributor: n/a - mefenamic acid - film-coated tablet - 250 mg